Molecular Modeling Revealed a "No-Go Zone" on the Cannabinoid Receptor That Blocks Inactive Compounds
Using computational modeling of active and inactive cannabinoids, researchers identified a specific region near the cannabinoid receptor where extra molecular volume prevents binding, explaining why some cannabinoid compounds are inactive.
Quick Facts
What This Study Found
Building on their earlier work on cannabinoid structure-activity relationships, researchers used the "active analog approach" to model a previously unknown feature of the cannabinoid receptor.
By comparing the three-dimensional shapes of four active cannabinoids with two inactive ones, they identified a region of "steric interference" near the receptor, essentially a physical space where extra molecular bulk prevents a compound from binding. They termed this the "receptor essential volume" (REV).
The REV was located near the top of the carbocyclic ring on the bottom face of the cannabinoid molecule. Active compounds had conformations that cleared this zone; inactive compounds could not avoid it.
The model was validated by testing it against additional cannabinoids: a minimally active classical cannabinoid, an active benzofuran cannabinoid, and the nonclassical cannabinoid CP-47,497. In each case, the compound's activity could be explained by whether its accessible conformations could clear the REV.
Key Numbers
Four active cannabinoids, two inactive cannabinoids used to define the model. Three additional compounds used for validation. The REV was mapped in three-dimensional space near the carbocyclic ring.
How They Did This
Computational molecular mechanics study using MMP2(85) for structure optimization and Chem-X MAP facility for calculating the receptor essential volume. Four active and two inactive cannabinoids were used to define the model, with three additional compounds used for validation.
Why This Research Matters
This study provided a molecular-level explanation for why some cannabinoid compounds are active and others are not, knowledge essential for designing new therapeutic cannabinoids with specific properties.
The Bigger Picture
This work contributed to the rational drug design approach for cannabinoid therapeutics. Understanding the physical constraints of the receptor binding site helps chemists design molecules that either fit (for therapeutic purposes) or are blocked (to create receptor antagonists).
What This Study Doesn't Tell Us
Computational modeling predicts but does not directly observe receptor interactions. The cannabinoid receptor structure was not yet experimentally determined at this time. Only a small set of compounds was used to define and test the model.
Questions This Raises
- ?Does the receptor essential volume model predict the activity of synthetic cannabinoids?
- ?How does this model compare to the actual receptor structure determined by X-ray crystallography?
- ?Can this approach guide design of non-psychoactive therapeutic cannabinoids?
Trust & Context
- Key Stat:
- A physical "no-go zone" at the receptor explained activity differences among cannabinoids
- Evidence Grade:
- A computational chemistry study with internal validation. Provides molecular insight but requires experimental confirmation of predictions.
- Study Age:
- Published in 1993. The CB1 receptor crystal structure was not solved until 2016, which ultimately confirmed many structural predictions from studies like this.
- Original Title:
- Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach.
- Published In:
- Journal of medicinal chemistry, 36(12), 1761-71 (1993)
- Authors:
- Reggio, P H(3), Panu, A M, Miles, S
- Database ID:
- RTHC-00048
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why are some cannabinoids inactive?
This study found that inactive cannabinoids have extra molecular volume that physically prevents them from fitting into a critical region near the receptor binding site.
How does this help drug development?
By mapping the physical constraints of receptor binding, chemists can design new compounds that either fit precisely (for therapeutic effects) or are deliberately blocked (for antagonist drugs).
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00048APA
Reggio, P H; Panu, A M; Miles, S. (1993). Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach.. Journal of medicinal chemistry, 36(12), 1761-71.
MLA
Reggio, P H, et al. "Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach.." Journal of medicinal chemistry, 1993.
RethinkTHC
RethinkTHC Research Database. "Characterization of a region of steric interference at the c..." RTHC-00048. Retrieved from https://rethinkthc.com/research/reggio-1993-characterization-of-a-region
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.